Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you think you took too much Wegovy, or accidentally took a dose too soon, the NHS and the medicine's prescribing information are clear: monitor how you feel, contact a healthcare professional, and call 111 or 999 if symptoms are severe. Semaglutide overdose is uncommon in clinical practice, but taking more than your prescribed dose (whether by injecting twice in one week or by using the wrong pen) carries real risks that are worth understanding calmly and clearly. These are prescription-only medicines, and any concern about dosing should go to your prescriber or a pharmacist, not a forum.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP clinical programme, including STEP 1, published in the New England Journal of Medicine, tested semaglutide 2.4mg over 68 weeks and characterised its side-effect profile carefully. The most consistent finding was that gastrointestinal effects (nausea, vomiting, loose stools, reflux) were dose-related: they peaked during dose escalation and settled as participants stayed on a stable dose. That dose-response relationship is part of why the titration schedule exists. Starting at 0.25mg and stepping up slowly is not arbitrary caution; it is based on data showing the body adapts to each level before moving to the next.
Taking too much semaglutide compresses that adaptation window. If you inject a second dose within the same week, or accidentally use a higher-strength pen than prescribed, you are effectively landing at a dose your system has not had time to adjust to. The result is typically a sharp worsening of nausea or vomiting. In people with type 2 diabetes also taking certain other medicines, low blood sugar is an additional risk, though semaglutide, a GLP-1 receptor agonist used for weight loss and blood sugar management, does not typically cause hypoglycaemia on its own. If you want to understand whether it is possible to take too much semaglutide and what that means in practice, that page covers the broader picture of how the medicine behaves alongside this one.
There is no antidote. Treatment is supportive: managing symptoms, staying hydrated, and resting.
The NHS medicines page for semaglutide is direct on this point. If you have taken more than your prescribed dose, contact a doctor or pharmacist as soon as possible. If your symptoms are severe (persistent vomiting you cannot control, signs of severe dehydration such as dizziness on standing, or any loss of consciousness) call 999 or go to your nearest A&E. For concerns that are not immediately dangerous, NHS 111 (call or online) is the right first step.
A question our prescribers hear most weeks is whether it is safe to simply skip the next scheduled dose after an accidental double injection. The honest answer is that this depends on when the error happened, which dose level you are on, and your individual circumstances. That is a prescriber conversation, not something to decide alone. If you are a nume patient and you are unsure, our support team is available seven days a week and can put you in touch with a prescriber.
Do not inject a replacement dose to compensate, and do not try to adjust your own schedule going forward without clinical guidance. The timing of each injection matters.
After taking too much Wegovy, most people experience an intensified version of the side effects described in the patient information leaflet: pronounced nausea, vomiting, stomach discomfort, and fatigue. These are unpleasant but not usually dangerous in otherwise healthy adults who can keep some fluid down. The situation changes if vomiting is severe enough that you cannot replace fluids. Dehydration can affect kidney function, and the MHRA has flagged this risk in the context of GLP-1 medicine safety communications.
Seek medical help promptly if you experience severe stomach pain that radiates to your back (a possible indicator of pancreatic inflammation), symptoms of a serious allergic reaction such as facial swelling or breathing difficulty, or signs of very low blood sugar if you are also on insulin or a sulphonylurea.
For mild-to-moderate nausea, sipping cold water or a clear electrolyte drink, eating small amounts of plain food once you feel able, and resting are the standard supportive steps. Avoid fatty or heavily seasoned food while symptoms persist. You can find broader guidance on managing what happens when eating on Wegovy triggers symptoms, which covers related practical advice.
Once you have spoken to a healthcare professional and the immediate situation is managed, the practical question becomes what to do the following week. The general principle in the Wegovy patient information leaflet is that if you missed your injection you take it as soon as you remember, but the situation after an accidental overdose is different, because you have had too much rather than too little. Your prescriber will advise whether to continue on the same schedule, delay the next dose, or step back to a lower strength while your system recovers.
This is not a decision to make by searching online. Guidance on managing the dose after an overdose incident sets out the considerations in more detail, and a practical step-by-step on what to do if you take too much walks through the immediate actions in sequence.
Wegovy is a prescription-only medicine. If you are looking for clinical support for your treatment going forward, or if you are considering starting treatment for the first time, you can speak to our prescribers through a free consultation, every review is done by a real GPhC-registered clinician, before every order.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.